Xenon Pharmaceuticals XENE
NASDAQ XENE
$38.93 +1.74 (+4.68%)
At close: Oct 1, 2026 · 4:00 PM EDT

Xenon Pharmaceuticals (XENE) Accumulated Depreciation (2021 - 2025)

Updated

Xenon Pharmaceuticals (XENE) reported Accumulated Depreciation of $15.45 million for Q4 2025, up 14.7% from $13.46 million a year earlier.

Analysis

Xenon Pharmaceuticals (XENE) Accumulated Depreciation (2021 - 2025) Analysis & Trends

Dating back to Q4 2021, Xenon Pharmaceuticals' Accumulated Depreciation record includes 5 quarters.

  • Accumulated Depreciation has increased for three consecutive years, with a four-year compound annual growth rate of 3.7% (FY2021 to FY2025).
  • By year, Accumulated Depreciation came in at $13.46 million in FY2024 (+19.7%), $11.25 million in FY2023 (+29.2%), $8.71 million in FY2022 (-34.8%) and $13.35 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Xenon Pharmaceuticals 3.60 Bn 3.60 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 15.45 Mn
Dec 31, 2024 13.46 Mn
Dec 31, 2023 11.25 Mn
Dec 31, 2022 8.71 Mn
Dec 31, 2021 13.35 Mn
API Access

Xenon Pharmaceuticals Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=XENE&period=max&api_key=YOUR_API_KEY